Arnd Kaldowski (born 1967, German citizen) joined the Sonova Group in October 2017 as Chief Operating Officer and became CEO as of April 1, 2018. He joined Sonova from Danaher Corporation, where he served in various leadership capacities since 2008, most recently as Group Executive of the Diagnostics Platform and President Beckman Coulter Diagnostics. Arnd Kaldowski led significant sales growth, innovation and productivity initiatives. He also brings significant experience and a successful track record in M&A, commercial excellence and new product introduction, which he gained in the course of his career at Danaher and as SVP Point-of-Care Solutions at Siemens Medical, following his previous assignments as Investment Director of Atila Ventures and as a Manager with the Boston Consulting Group.
Arnd Kaldowski holds a Master of Science in Physics from the Technical University Darmstadt, Germany, and an MBA from INSEAD in Fontainebleau, France.
Holdings as per 31.3.2019
- Shares1,2): 6,599
- Performance Share Units: 6,406
- Restricted Share Units: –
- Options: 119,444
1) Shares are dividend entitled with full voting rights. For further details see also Note 7.4 in the consolidated financial statements.
2) Member of the Management Board since October 1, 2017.